Strategy & Risk Oversight

6 Questions Boards Should Ask About Their Company’s Political Activity Strategy

While boards are generally not on the front line in making decisions about corporate political activity, they can play a key role in mitigating the risks and capitalizing on the opportunities.

Employees Need Time, Not Money, For Vaccination

Companies that want to boost inoculation among their employees should keep in mind the downsides of offering financial incentives. Some best practices for boards and management to consider.

Prepping For Proxy Season

ESG is back on boardroom agendas with a vengeance in 2021. Here’s what directors should be thinking about on each branch of the acronym.

CEOs And Covid: Winning In The Homestretch

How business leadership can help stop a two-year global health crisis from turning into a generational one.

Research Shows Boards Vigilantly Cautious On The Economic Recovery

As companies focus on capturing growth in a rebounding economy, public company directors are keeping a watchful eye on potential new risks amid the opportunities.

Hubert Joly: ‘The Whole Milton Friedman Thing Is Dead’

Joly made retail magic saving also-ran Best Buy in the age of Amazon. Now a corporate director, first-time author and HBS lecturer, he’s preaching a whole new way to win.

Corporate Board Member Institute

The leading continuing education program for public company boards.

Directors’ Outlook For Economy Dims To Pre-Vaccine Levels On Inflation Fears

Our gauge of U.S. public company board member confidence is now just 3 percent above where it was last fall, before Covid-19 vaccines were released.